pcDNA3.1-LGC-53
(Plasmid
#86399)
-
PurposeMammalian expression of codon-optimized dopamine receptor LGC-53
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 86399 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1(+)
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5357
- Total vector size (bp) 6884
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameLGC-53
-
Alt nameLigand-gated chloride channel
-
SpeciesC. elegans (nematode), Synthetic
-
Insert Size (bp)1528
-
MutationCodon optimized for mammalian expression; Signal sequence optimized to that of rat Gabra1. Amino acid changes R398A, R399A, R400A, R439A, R440A, R441A.
-
Entrez Genelgc-53 (a.k.a. CELE_T21F2.1)
- Promoter CMV
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site HindIII (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer CMV-F
- 3′ sequencing primer BGH-rev (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byInsert was created by Epoch Life Science, Inc (1306 FM-1092, Suite 407, Missouri City, TX 77459
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3.1-LGC-53 was a gift from Steven Mennerick (Addgene plasmid # 86399 ; http://n2t.net/addgene:86399 ; RRID:Addgene_86399) -
For your References section:
Fast phasic release properties of dopamine studied with a channel biosensor. Kress GJ, Shu HJ, Yu A, Taylor A, Benz A, Harmon S, Mennerick S. J Neurosci. 2014 Aug 27;34(35):11792-802. doi: 10.1523/JNEUROSCI.2355-14.2014. 10.1523/JNEUROSCI.2355-14.2014 PubMed 25164674